Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 2/2021

23.07.2020 | Case Reports

Device related thrombosis after left atrial appendage occlusion: does thrombus location always predicts its origin?

verfasst von: E. Flores-Umanzor, P. Cepas-Guillen, L. Sanchis, A. Regueiro, R. Navarro, S. Brugaletta, B. Vidal, M. Sitges, M. Sabaté, Xavier Freixa

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Excerpt

This is the case of a 65-year-old male with permanent atrial fibrillation (AF), CHA2DS2VASc of 7, and previous history of intracranial hemorrhage (ICH) under oral anticoagulation. The patient underwent left atrial appendage occlusion (LAAO) with the implant of a 25-mm Amulet device without complications. Device implantation was slightly deep, and pulmonary ridge was not covered by the device disc (Fig. 1a). The patient was discharged under dual antiplatelet treatment (DAPT). At 3 months, TEE showed a small thrombus below the pulmonary ridge (Fig. 1b). Considering the small size of the thrombus and previous history of ICH, DAPT was continued. A new TEE after 2 months showed a giant central protruding thrombus (25 × 23 mm) (Fig. 1c). DAPT was therefore substituted by apixaban 2.5 mg/12 h (adjusted for renal function). After 3 months, the size of the thrombus was clearly smaller (11 × 10 mm) (Fig. 1d), and apixaban was continued. Six months later, TEE showed complete DRT resolution (Fig. 1e). Aspirin was therefore started, and an additional TEEs showed no novel thrombus (Fig. 1f). The patient did not experience any symptom that could suggest an embolic event during the clinical follow-up.
Literatur
2.
Zurück zum Zitat Aminian A, Schmidt B, Mazzone P, et al. Incidence, characterization and clinical impact of device-related thrombus following left atrial appendage occlusion in the prospective global AMPLATZER Amulet Observational Study. JACC Cardiovasc Interv. 2019;12(11):1003–14.CrossRef Aminian A, Schmidt B, Mazzone P, et al. Incidence, characterization and clinical impact of device-related thrombus following left atrial appendage occlusion in the prospective global AMPLATZER Amulet Observational Study. JACC Cardiovasc Interv. 2019;12(11):1003–14.CrossRef
3.
Zurück zum Zitat Korsholm K, Jensen JM, Norgaard BL, et al. Detection of device related thrombosis following left atrial appendage occlusion: a comparison between cardiac computed tomography and transesophageal echocardiography. Circ Cardiovasc Interv. 2019;12(9):e008112.CrossRef Korsholm K, Jensen JM, Norgaard BL, et al. Detection of device related thrombosis following left atrial appendage occlusion: a comparison between cardiac computed tomography and transesophageal echocardiography. Circ Cardiovasc Interv. 2019;12(9):e008112.CrossRef
6.
Zurück zum Zitat Fauchier L, Cinaud A, Brigadeau F, et al. Device related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol. 2018;71(14):1528–36.CrossRef Fauchier L, Cinaud A, Brigadeau F, et al. Device related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation. J Am Coll Cardiol. 2018;71(14):1528–36.CrossRef
7.
Zurück zum Zitat Mill J, Olivares A, Arzamendi D, et al. Impact of flow dynamics on device related thrombosis after left atrial appendage occlusion. Can J Cardiol. 2020. In press;36:968.e13–4.CrossRef Mill J, Olivares A, Arzamendi D, et al. Impact of flow dynamics on device related thrombosis after left atrial appendage occlusion. Can J Cardiol. 2020. In press;36:968.e13–4.CrossRef
8.
Zurück zum Zitat Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903–12.CrossRef Connolly S, Pogue J, Hart R, et al. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial. Lancet. 2006;367:1903–12.CrossRef
Metadaten
Titel
Device related thrombosis after left atrial appendage occlusion: does thrombus location always predicts its origin?
verfasst von
E. Flores-Umanzor
P. Cepas-Guillen
L. Sanchis
A. Regueiro
R. Navarro
S. Brugaletta
B. Vidal
M. Sitges
M. Sabaté
Xavier Freixa
Publikationsdatum
23.07.2020
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 2/2021
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-020-00819-6

Weitere Artikel der Ausgabe 2/2021

Journal of Interventional Cardiac Electrophysiology 2/2021 Zur Ausgabe

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.